ClinicalTrials.gg
CompletedNCT04724915Updated Dec 9, 2024

Evaluation of Robot-assisted Total Knee Arthroplasty with Automatic Balancing

An interventional study of Conventional Total Knee Arthroplasty and Robot-Assisted Total Knee Arthroplasty in Osteoarthritis, Knee, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-12-09.

Sponsored by University Hospital, Ghent · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2020, registered Jan 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal is to evaluate the outcomes and learning curve of a robot-assisted total knee arthroplasty device with automatic ligament balancing.

02

Conditions studied

  • Osteoarthritis, Knee
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's enrollment of 60 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 685 studies on the registry; 158 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • End stage osteoarthritis of the knee joint with failed conservative treatment

Exclusion criteria

Exclusion Criteria:

  • Previous ligament trauma of the MCL/LCL
  • Previous fracture of femur or tibia
  • Fixed flexion contracture > 10°
  • Flexion \< 110°
  • Coronal deformity > 15°
  • Previous infection of the knee joint
  • Ligament insufficiency
  • Neurologic conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Robot-assisted TKA

    Patients undergoing TKA with the assistance of robot technology.

    Procedure: Robot-Assisted Total Knee Arthroplasty

  • Active comparator
    Conventional TKA

    Patients undergoing TKA with manual instrumentarium

    Procedure: Conventional Total Knee Arthroplasty

Interventions

  • ProcedureConventional Total Knee Arthroplasty

    People will undergo surgery to replace the knee joint with a prosthesis in case of osteoarthritis. This will be performed with manual instrumentarium (jig-based).

  • ProcedureRobot-Assisted Total Knee Arthroplasty

    People will undergo surgery to replace the knee joint with a prosthesis in case of osteoarthritis. This will be performed with the help of a surgical robot.

06

What researchers measure

Primary outcomes

  1. Knee Laxity

    Coronal knee laxity will be evaluated with stress examination. Coronal stress will be evaluated with a stress radiograph. The deviation between the neutral position and position under stress will be measured on a coronal radiograph. The angle between the joint lines will be measured on the coronal radiograph.

    Time frame: Preoperative and postoperatively at 1 year.

Secondary outcomes

  1. Patient reported outcome measures

    The following patient reported outcome measures will be evaluated: Knee Injury and Osteoarthritis outcome score. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems

    Time frame: Preoperative

  2. Patient reported outcome measures

    The following patient reported outcome measures will be evaluated: Knee Society Score. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Preoperative

  3. Patient reported outcome measures

    The following patient reported outcome measures will be evaluated: EuroQoL. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Preoperative

  4. Patient reported outcome measures

    The following patient reported outcome measures will be evaluated: Pain Catastrophizing Scale. The score is a percentage score from 0 to 52, 0 representing no problems and 52 representing extreme problems.

    Time frame: Preoperative

  5. Change in patient reported outcome measures

    The change for the following patient reported outcome measures will be evaluated (compared to preoperatively): Forgotten Joint Score. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Postoperatively at 6 weeks, 6 months, 1 year and 2 years.

  6. Change in patient reported outcome measures

    The change for the following patient reported outcome measures will be evaluated (compared to preoperatively): Knee Injury and Osteoarthritis outcome score. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Postoperatively at 6 weeks, 6 months, 1 year and 2 years.

  7. Change in patient reported outcome measures

    The change for the following patient reported outcome measures will be evaluated (compared to preoperatively): Knee Society Score. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Postoperatively at 6 weeks, 6 months, 1 year and 2 years.

  8. Change in patient reported outcome measures

    The change for the following patient reported outcome measures will be evaluated (compared to preoperatively): EuroQoL. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Time frame: Postoperatively at 6 weeks, 6 months, 1 year and 2 years.

  9. Change in patient reported outcome measures

    The change for the following patient reported outcome measures will be evaluated (compared to preoperatively): Pain Catastrophizing Scale. The score is a percentage score from 0 to 52, 0 representing no problems and 100 representing extreme problems.

    Time frame: Postoperatively at 6 weeks, 6 months, 1 year and 2 years.

  10. Alignment

    Coronal alignment on xrays. The lateral distal femoral angle (LDFA) will be evaluated. This is the angle between the mechanical femoral axis and the line between the distal articular surface of the femur. Additionally the medial proximal tibial angle (MPTA) will be evaluated. This is the line between the condylar surface and the mechanical axis of the tibia on a coronal radiograph.

    Time frame: Preoperative and postoperatively at 6 weeks and 6 months.

  11. Knee laxity anteroposterior

    Sagittal knee laxity will be evaluated with stress examination. Sagittal knee laxity will be measured with an anteroposterior laxitymeter (GENOUROB; CE Marked). With a standardized setup, anteroposterior laxity can be obtained by measuring the anteroposterior deviation from the neutral position with up to 300 Newton of force.

    Time frame: Preoperative and postoperatively at 1 year.

  12. Knee kinematics in 3D after squat, knee flexion/extension, stair ascend and descend.

    Knee kinematics in 3D obtained with fluoroscopy. Patients will be asked to perform squats, a flexion/extension movement, ascend and descend stairs. 3D motion of the prosthesis components can be obtained by projecting the 3D file of the prosthesis components onto the fluoroscopy images.

    Time frame: Postoperatively at 1 year.

07

Study locations

1 site
  • Ghent University Hospital
    Ghent, 9000, Belgium
08

References and documents

Publications

  • Vermue H, Arnout N, Tampere T, Stroobant L, Dereu A, Victor J. Standardized Intraoperative Robotic Laxity Assessment in TKA Leads to No Clinically Important Improvements at 2 Years Postoperatively: A Randomized Controlled Trial. Clin Orthop Relat Res. 2025 Oct 1;483(10):1866-1874. doi: 10.1097/CORR.0000000000003505. Epub 2025 Apr 16. PubMed 40258174 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2020 to primary completion in Aug 2024, 47 months.

Of 1,143 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 47 months is above that.

Counting every sponsor, half of 1,285 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2021
First posted
Jan 26, 2021
StartActual
Sep 1, 2020
Primary completionActual
Aug 30, 2024
CompletionActual
Aug 30, 2024
Last update
Dec 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04724915
Responsible party
Sponsor
First posted
Jan 26, 2021
Start date
Sep 1, 2020
Primary completion
Aug 30, 2024
Completion
Aug 30, 2024
Last update
Dec 9, 2024

Study contacts

Jan Victor, MD, PhD
study chair · UZ Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion